CA
TYRA icon

Cliff Asness’s Tyra Biosciences TYRA Stock Holding History

Cliff Asness’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$954K Buy
29,853
+430
+1% +$14.2K ﹤0.01% 3030
2026
Q1 		$1.13M Buy
29,423
+792
+3% +$25.6K ﹤0.01% 2695
2025
Q4 		$753K Buy
28,631
+562
+2% +$10.3K ﹤0.01% 2706
2025
Q3 		$393K Sell
28,069
-643
-2% -$7.33K ﹤0.01% 2936
2025
Q2 		$275K Buy
+28,712
New +$273K ﹤0.01% 2910

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Cliff Asness's TYRA Position: Q2 2026 in Review

Cliff Asness increased its Tyra Biosciences (TYRA) stake by 1.5% in Q2 2026, buying an estimated $14.2K and bringing the position to 29,853 shares worth $954K. The position accounts for ﹤0.01% of the portfolio, ranked #3030.

Cliff Asness first reported a position in TYRA in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.13M in Q1 2026. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Cliff Asness held 29,853 shares of Tyra Biosciences worth $954K as of Q2 2026.
  • Cliff Asness bought 430 Tyra Biosciences shares in Q2 2026, an estimated $14.2K.
  • Tyra Biosciences made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3030 holding.
  • Cliff Asness first reported a position in Tyra Biosciences in Q2 2025 and has held it in 5 quarters since.
  • Cliff Asness's Tyra Biosciences position peaked at $1.13M in Q1 2026.
  • 169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.